The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Sulfonamides-Global Market Insights and Sales Trends 2024
Synopsis
Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.
The global Sulfonamides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sulfonamides in various end use industries. The expanding demands from the Systemic Infection, Intestinal Infection, Burn Infection and Other Infections, are propelling Sulfonamides market. Intestinal Absorption, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intestinal Tract Difficult to Absorb segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sulfonamides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sulfonamides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sulfonamides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sulfonamides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sulfonamides covered in this report include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim, etc.
The global Sulfonamides market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Sanofi
Roche
Mylan
Teva
Bayer
Abbott
GlaxoSmithKline
Boehringer Ingelheim
Global Sulfonamides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sulfonamides market, Segment by Type:
Intestinal Absorption
Intestinal Tract Difficult to Absorb
External Use
Global Sulfonamides market, by Application
Systemic Infection
Intestinal Infection
Burn Infection
Other Infections
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sulfonamides companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Sulfonamides (sulphonamides) is a man-made group of medicines that includes the sulfonamide chemical group. Which is also called sulfa drugs. Sulfonamide antimicrobials are bacteriostatic (helps to stop generating new bacteria, but don’t surely kill them) and also work by intervening with the fusion of folic acid in bacteria, which is important for the formation of nucleic acid and ultimately for DNA and RNA. Sulfonamides are generally used in the pharmaceutical industry at a high rate. Where it is used as bacteriostatic agents which helps to kill the bacteria from human as well as from the animal’s body. Sulfonamides can be prepared in many ways in the laboratory. Sulfonamides are generally used for diabetes, fluid retention, high blood pressure, crohn’s disease, etc.
The global Sulfonamides market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Sulfonamides in various end use industries. The expanding demands from the Systemic Infection, Intestinal Infection, Burn Infection and Other Infections, are propelling Sulfonamides market. Intestinal Absorption, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Intestinal Tract Difficult to Absorb segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Sulfonamides, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Sulfonamides market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Sulfonamides market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Sulfonamides sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Sulfonamides covered in this report include Pfizer, Sanofi, Roche, Mylan, Teva, Bayer, Abbott, GlaxoSmithKline and Boehringer Ingelheim, etc.
The global Sulfonamides market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Pfizer
Sanofi
Roche
Mylan
Teva
Bayer
Abbott
GlaxoSmithKline
Boehringer Ingelheim
Global Sulfonamides market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Sulfonamides market, Segment by Type:
Intestinal Absorption
Intestinal Tract Difficult to Absorb
External Use
Global Sulfonamides market, by Application
Systemic Infection
Intestinal Infection
Burn Infection
Other Infections
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Sulfonamides companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Sulfonamides
1.1 Sulfonamides Market Overview
1.1.1 Sulfonamides Product Scope
1.1.2 Sulfonamides Market Status and Outlook
1.2 Global Sulfonamides Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Sulfonamides Market Size by Region (2018-2029)
1.4 Global Sulfonamides Historic Market Size by Region (2018-2023)
1.5 Global Sulfonamides Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Sulfonamides Market Size (2018-2029)
1.6.1 North America Sulfonamides Market Size (2018-2029)
1.6.2 Europe Sulfonamides Market Size (2018-2029)
1.6.3 Asia-Pacific Sulfonamides Market Size (2018-2029)
1.6.4 Latin America Sulfonamides Market Size (2018-2029)
1.6.5 Middle East & Africa Sulfonamides Market Size (2018-2029)
2 Sulfonamides Market by Type
2.1 Introduction
2.1.1 Intestinal Absorption
2.1.2 Intestinal Tract Difficult to Absorb
2.1.3 External Use
2.2 Global Sulfonamides Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Sulfonamides Historic Market Size by Type (2018-2023)
2.2.2 Global Sulfonamides Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Sulfonamides Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Sulfonamides Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Sulfonamides Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Sulfonamides Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Sulfonamides Revenue Breakdown by Type (2018-2029)
3 Sulfonamides Market Overview by Application
3.1 Introduction
3.1.1 Systemic Infection
3.1.2 Intestinal Infection
3.1.3 Burn Infection
3.1.4 Other Infections
3.2 Global Sulfonamides Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Sulfonamides Historic Market Size by Application (2018-2023)
3.2.2 Global Sulfonamides Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Sulfonamides Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Sulfonamides Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Sulfonamides Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Sulfonamides Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Sulfonamides Revenue Breakdown by Application (2018-2029)
4 Sulfonamides Competition Analysis by Players
4.1 Global Sulfonamides Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Sulfonamides as of 2022)
4.3 Date of Key Players Enter into Sulfonamides Market
4.4 Global Top Players Sulfonamides Headquarters and Area Served
4.5 Key Players Sulfonamides Product Solution and Service
4.6 Competitive Status
4.6.1 Sulfonamides Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Pfizer
5.1.1 Pfizer Profile
5.1.2 Pfizer Main Business
5.1.3 Pfizer Sulfonamides Products, Services and Solutions
5.1.4 Pfizer Sulfonamides Revenue (US$ Million) & (2018-2023)
5.1.5 Pfizer Recent Developments
5.2 Sanofi
5.2.1 Sanofi Profile
5.2.2 Sanofi Main Business
5.2.3 Sanofi Sulfonamides Products, Services and Solutions
5.2.4 Sanofi Sulfonamides Revenue (US$ Million) & (2018-2023)
5.2.5 Sanofi Recent Developments
5.3 Roche
5.3.1 Roche Profile
5.3.2 Roche Main Business
5.3.3 Roche Sulfonamides Products, Services and Solutions
5.3.4 Roche Sulfonamides Revenue (US$ Million) & (2018-2023)
5.3.5 Mylan Recent Developments
5.4 Mylan
5.4.1 Mylan Profile
5.4.2 Mylan Main Business
5.4.3 Mylan Sulfonamides Products, Services and Solutions
5.4.4 Mylan Sulfonamides Revenue (US$ Million) & (2018-2023)
5.4.5 Mylan Recent Developments
5.5 Teva
5.5.1 Teva Profile
5.5.2 Teva Main Business
5.5.3 Teva Sulfonamides Products, Services and Solutions
5.5.4 Teva Sulfonamides Revenue (US$ Million) & (2018-2023)
5.5.5 Teva Recent Developments
5.6 Bayer
5.6.1 Bayer Profile
5.6.2 Bayer Main Business
5.6.3 Bayer Sulfonamides Products, Services and Solutions
5.6.4 Bayer Sulfonamides Revenue (US$ Million) & (2018-2023)
5.6.5 Bayer Recent Developments
5.7 Abbott
5.7.1 Abbott Profile
5.7.2 Abbott Main Business
5.7.3 Abbott Sulfonamides Products, Services and Solutions
5.7.4 Abbott Sulfonamides Revenue (US$ Million) & (2018-2023)
5.7.5 Abbott Recent Developments
5.8 GlaxoSmithKline
5.8.1 GlaxoSmithKline Profile
5.8.2 GlaxoSmithKline Main Business
5.8.3 GlaxoSmithKline Sulfonamides Products, Services and Solutions
5.8.4 GlaxoSmithKline Sulfonamides Revenue (US$ Million) & (2018-2023)
5.8.5 GlaxoSmithKline Recent Developments
5.9 Boehringer Ingelheim
5.9.1 Boehringer Ingelheim Profile
5.9.2 Boehringer Ingelheim Main Business
5.9.3 Boehringer Ingelheim Sulfonamides Products, Services and Solutions
5.9.4 Boehringer Ingelheim Sulfonamides Revenue (US$ Million) & (2018-2023)
5.9.5 Boehringer Ingelheim Recent Developments
6 North America
6.1 North America Sulfonamides Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Sulfonamides Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Sulfonamides Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Sulfonamides Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Sulfonamides Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Sulfonamides Market Dynamics
11.1 Sulfonamides Industry Trends
11.2 Sulfonamides Market Drivers
11.3 Sulfonamides Market Challenges
11.4 Sulfonamides Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
